trial
as of 2026-07-01Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
NCTId NCT00345033
at a glance
Phase 4 · Completed
Enrollment 38 (actual)
Sponsored by Massachusetts General Hospital
Primary completion 2009-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2005-03
Primary completion
2009-10
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Massachusetts General HospitalLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
David C. Henderson, MDPrincipal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
38
Phase
PHASE4
Primary Completion Date
2009-10
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person